Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0001209191-21-032381

Director bought 10,000 shares at $3.19 ($31,947)

From the SEC's structured data for this filing

Trades in this filing

CONWAY ROBERT E · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-05-12 Purchase : show line 1 in the form +10,000 $3.19 $31,947 50,000 D
Open-market purchases · 10,000 sh · avg $3.19 · $31,947
Loading xslF345X03/doc4.xml…